Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02740361 · ClinicalTrials.gov registry record · NA
Online Program to Reduce Depression in MS
A NA study of Multiple Sclerosis, sponsored by Charite University, Berlin, Germany.
- Completed
- Registry status
- NA
- Development phase
- 279
- Enrollment target
- 5
- Study locations
NCT02740361 is a NA study of Multiple Sclerosis that has completed, run by Charite University, Berlin, Germany. The registered enrollment target is 279 participants, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (52% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT02740361, a NA study of Multiple Sclerosis, has completed, sponsored by Charite University, Berlin, Germany.
- COMPLETED
- Registry status
- NA
- Development phase
- 279 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is an international, multicenter, randomized controlled trial of an internet-based CBT intervention for depression (Deprexis) conducted in five MS centers in the US and Germany. The trial consists of a three-arm primary trial phase and an extension phase targeted at maintenance.
Conditions Studied
Interventions
- BEHAVIORAL Deprexis, DeprexisPlus
Study Locations (5)
California
- Cedars-Sinai Medical Center - Los Angeles
Kansas
- University of Missouri, Kansas City - Kansas City
Pennsylvania
- Penn State University - State College
Hamburg
- Universitätsklinikum Hamburg-Eppendorf - Hamburg
State of Berlin
- Charité University - Berlin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2021-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02740361
The ClinicalTrials.gov registry entry for NCT02740361 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 584-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (52% lower). The listed sponsor is Charite University, Berlin, Germany, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Deprexis, DeprexisPlus is the first listed.
NCT02740361 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Kansas, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02740361 about?
NCT02740361 is a clinical study titled "Online Program to Reduce Depression in MS". This is an international, multicenter, randomized controlled trial of an internet-based CBT intervention for depression (Deprexis) conducted in five MS centers in the US and Germany. The trial consists of a three-arm primary trial phase and an extension phase targeted at maintenance.
What is the current status of trial NCT02740361?
This trial is currently completed. It is a NA study. The enrollment target is 279 participants. The study started on 2017-02-15. Estimated completion is 2021-05-01.
What conditions does trial NCT02740361 study?
This clinical trial studies the following conditions: Multiple Sclerosis.
What interventions are being tested in trial NCT02740361?
The interventions under investigation include: Deprexis, DeprexisPlus (BEHAVIORAL).
Who is sponsoring clinical trial NCT02740361?
This trial is sponsored by Charite University, Berlin, Germany, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02740361 being conducted?
This trial has 5 study locations across California, Kansas, Pennsylvania, Hamburg, State of Berlin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.